<code id='4A643BC8F8'></code><style id='4A643BC8F8'></style>
    • <acronym id='4A643BC8F8'></acronym>
      <center id='4A643BC8F8'><center id='4A643BC8F8'><tfoot id='4A643BC8F8'></tfoot></center><abbr id='4A643BC8F8'><dir id='4A643BC8F8'><tfoot id='4A643BC8F8'></tfoot><noframes id='4A643BC8F8'>

    • <optgroup id='4A643BC8F8'><strike id='4A643BC8F8'><sup id='4A643BC8F8'></sup></strike><code id='4A643BC8F8'></code></optgroup>
        1. <b id='4A643BC8F8'><label id='4A643BC8F8'><select id='4A643BC8F8'><dt id='4A643BC8F8'><span id='4A643BC8F8'></span></dt></select></label></b><u id='4A643BC8F8'></u>
          <i id='4A643BC8F8'><strike id='4A643BC8F8'><tt id='4A643BC8F8'><pre id='4A643BC8F8'></pre></tt></strike></i>

          leisure time

          leisure time

          author:knowledge    Page View:37579
          Rachel Haurwitz of Caribou Biosciences
          Rachel Haurwitz, CEO of Caribou Biosciences. Elizabeth D. Herman for STAT

          Caribou Biosciences said Thursday that its off-the-shelf CAR-T therapy induced durable, complete remissions in patients with advanced B-cell lymphoma that move it closer to the benchmarks set by more established, patient-specific CAR-T therapies.

          In an update to an early-stage study, 44% of the 16 patients treated with Caribou’s on-demand therapy, called CB-010, achieved a complete remission lasting a minimum of six months — a key threshold of durability.

          advertisement

          The CB-010 result is still preliminary, but it begins to compare favorably to currently approved CAR-T therapies, which must be custom made for each patient and have shown durable remission rates in the range of 36-40%, said Caribou CEO Rachel Haurwitz.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections
          Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

          FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

          read more
          In science, is the line between industry and academia shifting?
          In science, is the line between industry and academia shifting?

          AkiraSuemori/APAfewyearsago,VijayPande,thenaprofessoratStanfordwhowasusingcomputersciencetounderstan

          read more
          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more

          NYU Langone launches private ChatGPT for its health care data

          VincentMajor(left)andCristinaGonzalezattheprompt-a-thonorganizedbyNYULangone.CourtesyJoeCarrotta/NYU